Pierre Attali

Pierre Attali

Pierre Attali
Chief Operating Officer, BioAlliance Pharma

Pierre Attali, MD, MSc, has been working in academic hospitals in Paris for 11 years as specialist in liver diseases before joining Synthelabo Research Clinical Department as study manager. He was rapidly promoted as project leader, group head, section head, and eventually in 1992 Head of the Clinical Research Department, managing 300-400 people in charge of clinical strategy and worldwide clinical operations. He personally brought 3 new chemical entities and several new formulations to the market, and through its management, many others. After the merger with Sanofi, he co-founded in 2000, and managed as CEO, OSMO, a CRO specialized in oncology. He then successively joined as CEO Molecular Engines Laboratories, a French biotech company dedicated to oncology, and later Urogene before joining BioAlliance. He still has medical functions in Bicêtre and Paul Brousse hospitals (Assistance Publique-Hôpitaux de Paris) where he has consultations and acts as principal investigator in several clinical trials in liver diseases. He is cofounder and board member of several specialty pharma and biotech companies.

Contact

International Economic Forum
of the Americas
2075 Robert-Bourassa Blvd.
Suite 1701
Montreal, Quebec
H3A 2L1 Canada

Telephone: 514 871-2225
Toll-free phone: 1 866 865-2225
Fax: 514 871-2226